Page 59 - TD-3-2

Tumor Discovery High-grade sinonasal adenocarcinoma

Funding 00225>3.0.co;2-z

None. 5. Breda M, Miranda D, Pereira S, et al. Sinonasal
adenocarcinoma - Hospital de Braga ENT department
Conflict of interest expertise. Port J Otorhinolaryngol Head Neck Surg.
2017;54(4):233-238.
The authors declare that they have no competing interests.
6. Lund VJ, Stammberger H, Nicolai P, et al. European position
Author contributions paper on endoscopic management of tumours of the nose,
paranasal sinuses and skull base. Rhinol Suppl. 2010;22:1-
Conceptualization: Sara Moujrid, Fadoua El Mourabit 143.
Investigation: Sara Moujrid, Fadoua El Mourabit 7. Madani I, Bonte K, Vakaet L, Boterberg T, De Neve W.
Methodology: Sara Moujrid, Fadoua El Mourabit Intensity-modulated radiotherapy for sinonasal tumors:
Writing – original draft: Sara Moujrid, Fadoua El Mourabit Ghent University Hospital update. Int J Radiat Oncol Biol
Writing - review & editing: All authors Phys. 2009;73(2):424-432.
Ethics approval and consent to participate doi: 10.1016/j.ijrobp.2008.04.037
8. Bignami M, Lepera D, Volpi L, et al. Sinonasal non-
Verbal consent had been obtained from the patient before intestinal-type adenocarcinoma: A retrospective review of
participation. 22 patients. World Neurosurg. 2018;120:e962-e969.
Consent for publication doi: 10.1016/j.wneu.2018.08.201

Verbal consent had been obtained from the patient 9. Stelow EB, Mills SE, Jo VY, Carlson DL. Adenocarcinoma
for publishing this case report while maintaining his of the upper aerodigestive tract. Adv Anat Pathol.
2010;17(4):262-269.
anonymity.
doi: 10.1097/PAP.0b013e3181e3bf80
Availability of data 10. Jain C, Caulley L, Macdonald KI, et al. Nasopharyngeal non-

Not applicable. intestinal-type adenocarcinoma: A case report and updated
review of the literature. Curr Oncol. 2017;24(1):e55-e60.
References doi: 10.3747/co.24.3299

1. Thompson LDR, Loney EL, Bishop JA, et al. Nasal, 11. Choussy O, Ferron C, Vedrine PO, et al. Adenocarcinoma
paranasal, and skull base tumours. In: WHO Classification of ethmoid: A GETTEC retrospective multicenter study of
of Tumours Editorial Board. Head and Neck Tumours. Ch. 2. 418 cases. Laryngoscope. 2008;118(3):437-443.
Lyon, France: International Agency for Research on Cancer;
2022. [Last accessed on 2023 May 08]. doi: 10.1097/MLG.0b013e31815b48e3
2. Pradhan P, Panigrahi R, Misra P, Senapati U, Samantaray K. 12. Verma V, Mendenhall WM, Werning JW. Polymorphous
High-grade non-salivary non-intestinal adenocarcinoma of low-grade adenocarcinoma of the head and neck. Am J Clin
the nasal cavity - A less known entity. Int J Otorhinolaryngol Oncol. 2014;37(6):624-626.
Head Neck Surg. 2020;6(11):2163-2164. doi: 10.1097/COC.0b013e31827e5537
3. Turner JH, Reh DD. Incidence and survival in patients with 13. Neto AG, Pineda-Daboin K, Luna MA. Sinonasal tract
sinonasal cancer: A historical analysis of population-based seromucous adenocarcinomas: A report of 12 cases. Ann
data. Head Neck. 2012;34(6):877-885. Diagn Pathol. 2004;7:154-159.
doi: 10.1002/hed.21830 doi: 10.1016/s1092-9134(03)00012-1
4. Heffner DK, Hyams VJ, Hauck KW, Lingeman C. Low-grade 14. Kilic S, Samarrai R, Kilic SS, Mikhael M, Baredes S, Eloy JA.
adenocarcinoma of the nasal cavity and paranasal sinuses. Incidence and survival of sinonasal adenocarcinoma by site
Cancer. 1982;50(2):312-322. and histologic subtype. Acta Otolaryngol. 2018;138(4):415-421.
doi: 10.1002/1097-0142(19820715)50:2<312:aid-cncr28205 doi: 10.1080/00016489.2017.1401229

Volume 3 Issue 2 (2024) 5 doi: 10.36922/td.2423